Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
No additional AE; 24-year-old female patient received PROQUAD; This spontaneous report was received from a other health professional and refers to a 24-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 14-AUG-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), 0.5 mL (route of administration, anatomical location, lot number and expiration date was not reported) for prophylaxis, the vaccine was reconstituted with sterile diluent (HOLLISTER STERILE DILUENT), (lot number and expiration date not reported) (Product administered to patient of inappropriate age). There was not adverse event reported (No adverse event).